Anti-neuropathic effect of 7,3'-dihydroxyflavone in paclitaxel induced peripheral neuropathy in mice involving GABAA, KATP channel and adenosine receptors

Neurochem Int. 2022 Oct:159:105388. doi: 10.1016/j.neuint.2022.105388. Epub 2022 Jul 6.

Abstract

Peripheral neuropathy induced by chemotherapeutic agents is the most common dose-limiting adverse effect observed in patients during and after treatment of malignancies. Many flavones have been reported to ameliorate neuropathy of different origin in experimental animals and their possible mode of action explored. The present study aims to investigate 7,3'-dihydroxyflavone for its anti-neuropathic effect against paclitaxel induced peripheral neuropathy in mice by employing behavioural tests such as mechanical allodynia, cold allodynia and thermal hyperalgesia. The possible involvement of GABAA, KATP channels and adenosine receptors in the anti-neuropathic effect of 7,3'-dihydroxyflavone was also studied by employing suitable interacting drugs. Treatment with 7,3'-dihydroxyflavone (50, 100 or 200 mg/kg, s.c) significantly and dose-dependently reduced the paw withdrawal response score in both mechanical and cold allodynia and also increased the tail flick response time in thermal hyperalgesia due to paclitaxel-induced neuropathy. Pre-treatment with glibenclamide (10 mg/kg, i.p), caffeine (50 mg/kg, i.p) or bicuculline (2 mg/kg, i.p) significantly reversed the anti-neuropathic effect of 7,3'-dihydroxyflavone in behavioral tests. In conclusion, the present investigation identified 7,3'-dihydroxyflavone as a potential candidate with anti-neuropathic effect against paclitaxel induced peripheral neuropathy involving KATP channels, adenosine and GABAA receptors.

Keywords: Adenosine receptor; Chemotherapy-induced peripheral neuropathy; Dihydroxyflavone; GABA(A) receptor; K(ATP) channel.

MeSH terms

  • Adenosine Triphosphate
  • Animals
  • Hyperalgesia / chemically induced
  • Hyperalgesia / drug therapy
  • Mice
  • Paclitaxel* / toxicity
  • Peripheral Nervous System Diseases* / chemically induced
  • Peripheral Nervous System Diseases* / drug therapy
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P1 / therapeutic use
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Receptors, Purinergic P1
  • gamma-Aminobutyric Acid
  • Adenosine Triphosphate
  • Paclitaxel